Loading... Please wait.

Company profile

ATON is a medical science group committed to the future of medicine, with the aim of improving patient care and the safety and efficacy of treatments. ATON guides and develops a portfolio of cutting-edge companies, each with its own specialty, working in synergy to advance the medicine of today and tomorrow.

Source: Cofisem - Last Update: 31 Oct 2024
Key Executives
Chairman and Chief Executive Officer Ayikoélé Atayi
Source: Cofisem - Last Update: 31 Oct 2024
Key figures
Millenium 2023 2022 2021 2020 2019
Net sales 382.151 1.560 0 -96 234.926
Consumed purchases 530.181 212.213 256.514 236.061 803.043
Labour costs 558.836 372.541 0 210.350 770.174
Operating profit -753.177 -590.145 -123.294 -317.105 -1.360.564
Income tax 0 0 0 0 -60.408
Net income -18.846.501 -563.570 -69.159 -326.679 -735.507
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - unit EUR - unit EUR - unit EUR - unit EUR - unit
Account Standards French_GAAP French_GAAP French_GAAP French_GAAP French_GAAP
Source: Cofisem - Last Update: 31 Oct 2024
Shareholder information
Ayikoélé Atayi 0,47 %
Pierre Eftekhari 7,89 %
Diagnostic Medical Systems 17,70 %
Free float 61,79 %
Ansel Family Group 12,15 %
Source: Cofisem - Last Update: 31 Oct 2024

Address

ATON

850 Boulevard du Sébastien Brant
FR-67400 Illkirch-Graffenstaden
France
Phone number: +33 (0)9 72 56 94 99
Source: Cofisem - Last Update: 31 Oct 2024

Contact

Léone Atayi
Source: ATON - Last Update: 31 Oct 2024